Published comparison; transcribed, not reproduced.
These checks assess whether the evidence supports a reproducible investigation. A source-checked score alone does not meet these requirements.
Release 2026-10-09-ba02f2f4a36e · Evidence verified: Not verified
Exact outcomes, predictions, identifiers and evaluator are connected.
Missing or unresolved evidence
Verified: Not verified
Replay evidence includes annotations and an assessment of dependence. Unknown independence permits descriptive analysis only.
Missing or unresolved evidence
Verified: Not verified
A pinned recipe describes the inputs, environment and resource requirements.
Missing or unresolved evidence
Verified: Not verified
Separate data and exposure records support an independent test.
Missing or unresolved evidence
Verified: Not verified
Readiness describes the evidence in this release. Availability on your computer is checked separately when an investigation runs. Existing data exposure can prevent independent validation even when files are available.
No verified artifact manifest is connected to this record yet. The gaps above identify what is needed before analysis can begin.
1 evaluation · 22 results. Different protocols are not a single leaderboard.
Applied filters: All linked evaluations
| Tested configuration | Protocol and dataset | Finding | Evidence and details |
|---|---|---|---|
| Configuration: SPOT-MAS tissue-of-origin Random forest (RF) | Protocol: SPOT-MAS five-class tissue of origin, independent validation cohort Dataset: SPOT-MAS validation cohort, 239 non-metastatic cancer patients (five cancer types) | 0.53 accuracy fraction · higher Uncertainty: Not reported by the source Coverage: 239 cancer patients scored (n printed in cell B19) | Author-reported evaluation · Source checkedMethods, coverage and sourceSPOT-MAS tissue of origin, RF (validation) ctdnameth-20261009-protocol-nguyen2023-spotmas-too-validation Aggregation: Not reported Multimodal analysis of methylomics and fragmentomics in plasma cell-free DNA for multi-cancer early detection and localization; Nguyen et al. 2023, Supplementary file 1 (Tables S1-S11) · Supplementary file 1, sheet 'Table S9', C19; Validation block; row 'All cancer'; column 'RF' under 'All stage' (n in B19) |
| Configuration: SPOT-MAS tissue-of-origin Random forest (RF) | Protocol: SPOT-MAS five-class tissue of origin, independent validation cohort Dataset: SPOT-MAS validation cohort, 239 non-metastatic cancer patients (five cancer types) | 0.79 recall fraction · higher Uncertainty: Not reported by the source Coverage: 67 cancer patients scored (n printed in cell B14) | Author-reported evaluation · Source checkedMethods, coverage and sourceSPOT-MAS tissue of origin, RF (validation) ctdnameth-20261009-protocol-nguyen2023-spotmas-too-validation Aggregation: Not reported Multimodal analysis of methylomics and fragmentomics in plasma cell-free DNA for multi-cancer early detection and localization; Nguyen et al. 2023, Supplementary file 1 (Tables S1-S11) · Supplementary file 1, sheet 'Table S9', C14; Validation block; row 'Breast'; column 'RF' under 'All stage' (n in B14) |
| Configuration: SPOT-MAS tissue-of-origin Random forest (RF) | Protocol: SPOT-MAS five-class tissue of origin, independent validation cohort Dataset: SPOT-MAS validation cohort, 239 non-metastatic cancer patients (five cancer types) | 0.38 recall fraction · higher Uncertainty: Not reported by the source Coverage: 53 cancer patients scored (n printed in cell B15) | Author-reported evaluation · Source checkedMethods, coverage and sourceSPOT-MAS tissue of origin, RF (validation) ctdnameth-20261009-protocol-nguyen2023-spotmas-too-validation Aggregation: Not reported Multimodal analysis of methylomics and fragmentomics in plasma cell-free DNA for multi-cancer early detection and localization; Nguyen et al. 2023, Supplementary file 1 (Tables S1-S11) · Supplementary file 1, sheet 'Table S9', C15; Validation block; row 'CRC'; column 'RF' under 'All stage' (n in B15) |
| Configuration: SPOT-MAS tissue-of-origin Random forest (RF) | Protocol: SPOT-MAS five-class tissue of origin, independent validation cohort Dataset: SPOT-MAS validation cohort, 239 non-metastatic cancer patients (five cancer types) | 0.6 recall fraction · higher Uncertainty: Not reported by the source Coverage: 5 cancer patients scored (n printed in cell F15) | Author-reported evaluation · Source checkedMethods, coverage and sourceSPOT-MAS tissue of origin, RF (validation) ctdnameth-20261009-protocol-nguyen2023-spotmas-too-validation Aggregation: Not reported Multimodal analysis of methylomics and fragmentomics in plasma cell-free DNA for multi-cancer early detection and localization; Nguyen et al. 2023, Supplementary file 1 (Tables S1-S11) · Supplementary file 1, sheet 'Table S9', G15; Validation block; row 'CRC'; column 'RF' under 'Stage I' (n in F15) |
| Configuration: SPOT-MAS tissue-of-origin Random forest (RF) | Protocol: SPOT-MAS five-class tissue of origin, independent validation cohort Dataset: SPOT-MAS validation cohort, 239 non-metastatic cancer patients (five cancer types) | 0.3 recall fraction · higher Uncertainty: Not reported by the source Coverage: 20 cancer patients scored (n printed in cell J15) | Author-reported evaluation · Source checkedMethods, coverage and sourceSPOT-MAS tissue of origin, RF (validation) ctdnameth-20261009-protocol-nguyen2023-spotmas-too-validation Aggregation: Not reported Multimodal analysis of methylomics and fragmentomics in plasma cell-free DNA for multi-cancer early detection and localization; Nguyen et al. 2023, Supplementary file 1 (Tables S1-S11) · Supplementary file 1, sheet 'Table S9', K15; Validation block; row 'CRC'; column 'RF' under 'Stage II' (n in J15) |
| Configuration: SPOT-MAS tissue-of-origin Random forest (RF) | Protocol: SPOT-MAS five-class tissue of origin, independent validation cohort Dataset: SPOT-MAS validation cohort, 239 non-metastatic cancer patients (five cancer types) | 0.45 recall fraction · higher Uncertainty: Not reported by the source Coverage: 20 cancer patients scored (n printed in cell N15) | Author-reported evaluation · Source checkedMethods, coverage and sourceSPOT-MAS tissue of origin, RF (validation) ctdnameth-20261009-protocol-nguyen2023-spotmas-too-validation Aggregation: Not reported Multimodal analysis of methylomics and fragmentomics in plasma cell-free DNA for multi-cancer early detection and localization; Nguyen et al. 2023, Supplementary file 1 (Tables S1-S11) · Supplementary file 1, sheet 'Table S9', O15; Validation block; row 'CRC'; column 'RF' under 'Stage III' (n in N15) |
| Configuration: SPOT-MAS tissue-of-origin Random forest (RF) | Protocol: SPOT-MAS five-class tissue of origin, independent validation cohort Dataset: SPOT-MAS validation cohort, 239 non-metastatic cancer patients (five cancer types) | 0.25 recall fraction · higher Uncertainty: Not reported by the source Coverage: 8 cancer patients scored (n printed in cell R15) | Author-reported evaluation · Source checkedMethods, coverage and sourceSPOT-MAS tissue of origin, RF (validation) ctdnameth-20261009-protocol-nguyen2023-spotmas-too-validation Aggregation: Not reported Multimodal analysis of methylomics and fragmentomics in plasma cell-free DNA for multi-cancer early detection and localization; Nguyen et al. 2023, Supplementary file 1 (Tables S1-S11) · Supplementary file 1, sheet 'Table S9', S15; Validation block; row 'CRC'; column 'RF' under 'Non-metastasis with unknown stage' (n in R15) |
| Configuration: SPOT-MAS tissue-of-origin Random forest (RF) | Protocol: SPOT-MAS five-class tissue of origin, independent validation cohort Dataset: SPOT-MAS validation cohort, 239 non-metastatic cancer patients (five cancer types) | 0.19 recall fraction · higher Uncertainty: Not reported by the source Coverage: 31 cancer patients scored (n printed in cell B16) | Author-reported evaluation · Source checkedMethods, coverage and sourceSPOT-MAS tissue of origin, RF (validation) ctdnameth-20261009-protocol-nguyen2023-spotmas-too-validation Aggregation: Not reported Multimodal analysis of methylomics and fragmentomics in plasma cell-free DNA for multi-cancer early detection and localization; Nguyen et al. 2023, Supplementary file 1 (Tables S1-S11) · Supplementary file 1, sheet 'Table S9', C16; Validation block; row 'Gastric'; column 'RF' under 'All stage' (n in B16) |
| Configuration: SPOT-MAS tissue-of-origin Random forest (RF) | Protocol: SPOT-MAS five-class tissue of origin, independent validation cohort Dataset: SPOT-MAS validation cohort, 239 non-metastatic cancer patients (five cancer types) | 1 recall fraction · higher Uncertainty: Not reported by the source Coverage: 2 cancer patients scored (n printed in cell F16) | Author-reported evaluation · Source checkedMethods, coverage and sourceSPOT-MAS tissue of origin, RF (validation) ctdnameth-20261009-protocol-nguyen2023-spotmas-too-validation Aggregation: Not reported Multimodal analysis of methylomics and fragmentomics in plasma cell-free DNA for multi-cancer early detection and localization; Nguyen et al. 2023, Supplementary file 1 (Tables S1-S11) · Supplementary file 1, sheet 'Table S9', G16; Validation block; row 'Gastric'; column 'RF' under 'Stage I' (n in F16) |
| Configuration: SPOT-MAS tissue-of-origin Random forest (RF) | Protocol: SPOT-MAS five-class tissue of origin, independent validation cohort Dataset: SPOT-MAS validation cohort, 239 non-metastatic cancer patients (five cancer types) | 0.4 recall fraction · higher Uncertainty: Not reported by the source Coverage: 5 cancer patients scored (n printed in cell J16) | Author-reported evaluation · Source checkedMethods, coverage and sourceSPOT-MAS tissue of origin, RF (validation) ctdnameth-20261009-protocol-nguyen2023-spotmas-too-validation Aggregation: Not reported Multimodal analysis of methylomics and fragmentomics in plasma cell-free DNA for multi-cancer early detection and localization; Nguyen et al. 2023, Supplementary file 1 (Tables S1-S11) · Supplementary file 1, sheet 'Table S9', K16; Validation block; row 'Gastric'; column 'RF' under 'Stage II' (n in J16) |
| Configuration: SPOT-MAS tissue-of-origin Random forest (RF) | Protocol: SPOT-MAS five-class tissue of origin, independent validation cohort Dataset: SPOT-MAS validation cohort, 239 non-metastatic cancer patients (five cancer types) | 0.2 recall fraction · higher Uncertainty: Not reported by the source Coverage: 10 cancer patients scored (n printed in cell N16) | Author-reported evaluation · Source checkedMethods, coverage and sourceSPOT-MAS tissue of origin, RF (validation) ctdnameth-20261009-protocol-nguyen2023-spotmas-too-validation Aggregation: Not reported Multimodal analysis of methylomics and fragmentomics in plasma cell-free DNA for multi-cancer early detection and localization; Nguyen et al. 2023, Supplementary file 1 (Tables S1-S11) · Supplementary file 1, sheet 'Table S9', O16; Validation block; row 'Gastric'; column 'RF' under 'Stage III' (n in N16) |
| Configuration: SPOT-MAS tissue-of-origin Random forest (RF) | Protocol: SPOT-MAS five-class tissue of origin, independent validation cohort Dataset: SPOT-MAS validation cohort, 239 non-metastatic cancer patients (five cancer types) | 0 recall fraction · higher Uncertainty: Not reported by the source Coverage: 14 cancer patients scored (n printed in cell R16) | Author-reported evaluation · Source checkedMethods, coverage and sourceSPOT-MAS tissue of origin, RF (validation) ctdnameth-20261009-protocol-nguyen2023-spotmas-too-validation Aggregation: Not reported Multimodal analysis of methylomics and fragmentomics in plasma cell-free DNA for multi-cancer early detection and localization; Nguyen et al. 2023, Supplementary file 1 (Tables S1-S11) · Supplementary file 1, sheet 'Table S9', S16; Validation block; row 'Gastric'; column 'RF' under 'Non-metastasis with unknown stage' (n in R16) |
| Configuration: SPOT-MAS tissue-of-origin Random forest (RF) | Protocol: SPOT-MAS five-class tissue of origin, independent validation cohort Dataset: SPOT-MAS validation cohort, 239 non-metastatic cancer patients (five cancer types) | 0.62 recall fraction · higher Uncertainty: Not reported by the source Coverage: 45 cancer patients scored (n printed in cell B17) | Author-reported evaluation · Source checkedMethods, coverage and sourceSPOT-MAS tissue of origin, RF (validation) ctdnameth-20261009-protocol-nguyen2023-spotmas-too-validation Aggregation: Not reported Multimodal analysis of methylomics and fragmentomics in plasma cell-free DNA for multi-cancer early detection and localization; Nguyen et al. 2023, Supplementary file 1 (Tables S1-S11) · Supplementary file 1, sheet 'Table S9', C17; Validation block; row 'Liver'; column 'RF' under 'All stage' (n in B17) |
| Configuration: SPOT-MAS tissue-of-origin Random forest (RF) | Protocol: SPOT-MAS five-class tissue of origin, independent validation cohort Dataset: SPOT-MAS validation cohort, 239 non-metastatic cancer patients (five cancer types) | 1 recall fraction · higher Uncertainty: Not reported by the source Coverage: 2 cancer patients scored (n printed in cell F17) | Author-reported evaluation · Source checkedMethods, coverage and sourceSPOT-MAS tissue of origin, RF (validation) ctdnameth-20261009-protocol-nguyen2023-spotmas-too-validation Aggregation: Not reported Multimodal analysis of methylomics and fragmentomics in plasma cell-free DNA for multi-cancer early detection and localization; Nguyen et al. 2023, Supplementary file 1 (Tables S1-S11) · Supplementary file 1, sheet 'Table S9', G17; Validation block; row 'Liver'; column 'RF' under 'Stage I' (n in F17) |
| Configuration: SPOT-MAS tissue-of-origin Random forest (RF) | Protocol: SPOT-MAS five-class tissue of origin, independent validation cohort Dataset: SPOT-MAS validation cohort, 239 non-metastatic cancer patients (five cancer types) | 0.7 recall fraction · higher Uncertainty: Not reported by the source Coverage: 10 cancer patients scored (n printed in cell J17) | Author-reported evaluation · Source checkedMethods, coverage and sourceSPOT-MAS tissue of origin, RF (validation) ctdnameth-20261009-protocol-nguyen2023-spotmas-too-validation Aggregation: Not reported Multimodal analysis of methylomics and fragmentomics in plasma cell-free DNA for multi-cancer early detection and localization; Nguyen et al. 2023, Supplementary file 1 (Tables S1-S11) · Supplementary file 1, sheet 'Table S9', K17; Validation block; row 'Liver'; column 'RF' under 'Stage II' (n in J17) |
| Configuration: SPOT-MAS tissue-of-origin Random forest (RF) | Protocol: SPOT-MAS five-class tissue of origin, independent validation cohort Dataset: SPOT-MAS validation cohort, 239 non-metastatic cancer patients (five cancer types) | 0.6 recall fraction · higher Uncertainty: Not reported by the source Coverage: 15 cancer patients scored (n printed in cell N17) | Author-reported evaluation · Source checkedMethods, coverage and sourceSPOT-MAS tissue of origin, RF (validation) ctdnameth-20261009-protocol-nguyen2023-spotmas-too-validation Aggregation: Not reported Multimodal analysis of methylomics and fragmentomics in plasma cell-free DNA for multi-cancer early detection and localization; Nguyen et al. 2023, Supplementary file 1 (Tables S1-S11) · Supplementary file 1, sheet 'Table S9', O17; Validation block; row 'Liver'; column 'RF' under 'Stage III' (n in N17) |
| Configuration: SPOT-MAS tissue-of-origin Random forest (RF) | Protocol: SPOT-MAS five-class tissue of origin, independent validation cohort Dataset: SPOT-MAS validation cohort, 239 non-metastatic cancer patients (five cancer types) | 0.56 recall fraction · higher Uncertainty: Not reported by the source Coverage: 18 cancer patients scored (n printed in cell R17) | Author-reported evaluation · Source checkedMethods, coverage and sourceSPOT-MAS tissue of origin, RF (validation) ctdnameth-20261009-protocol-nguyen2023-spotmas-too-validation Aggregation: Not reported Multimodal analysis of methylomics and fragmentomics in plasma cell-free DNA for multi-cancer early detection and localization; Nguyen et al. 2023, Supplementary file 1 (Tables S1-S11) · Supplementary file 1, sheet 'Table S9', S17; Validation block; row 'Liver'; column 'RF' under 'Non-metastasis with unknown stage' (n in R17) |
| Configuration: SPOT-MAS tissue-of-origin Random forest (RF) | Protocol: SPOT-MAS five-class tissue of origin, independent validation cohort Dataset: SPOT-MAS validation cohort, 239 non-metastatic cancer patients (five cancer types) | 0.44 recall fraction · higher Uncertainty: Not reported by the source Coverage: 43 cancer patients scored (n printed in cell B18) | Author-reported evaluation · Source checkedMethods, coverage and sourceSPOT-MAS tissue of origin, RF (validation) ctdnameth-20261009-protocol-nguyen2023-spotmas-too-validation Aggregation: Not reported Multimodal analysis of methylomics and fragmentomics in plasma cell-free DNA for multi-cancer early detection and localization; Nguyen et al. 2023, Supplementary file 1 (Tables S1-S11) · Supplementary file 1, sheet 'Table S9', C18; Validation block; row 'Lung'; column 'RF' under 'All stage' (n in B18) |
| Configuration: SPOT-MAS tissue-of-origin Random forest (RF) | Protocol: SPOT-MAS five-class tissue of origin, independent validation cohort Dataset: SPOT-MAS validation cohort, 239 non-metastatic cancer patients (five cancer types) | N/A recall fraction · higher Uncertainty: Not reported by the source Coverage: 0 cancer patients scored (n printed in cell F18) | Author-reported evaluation · Source checkedMethods, coverage and sourceSPOT-MAS tissue of origin, RF (validation) ctdnameth-20261009-protocol-nguyen2023-spotmas-too-validation Aggregation: Not reported Multimodal analysis of methylomics and fragmentomics in plasma cell-free DNA for multi-cancer early detection and localization; Nguyen et al. 2023, Supplementary file 1 (Tables S1-S11) · Supplementary file 1, sheet 'Table S9', G18; Validation block; row 'Lung'; column 'RF' under 'Stage I' (n in F18) |
| Configuration: SPOT-MAS tissue-of-origin Random forest (RF) | Protocol: SPOT-MAS five-class tissue of origin, independent validation cohort Dataset: SPOT-MAS validation cohort, 239 non-metastatic cancer patients (five cancer types) | 0.33 recall fraction · higher Uncertainty: Not reported by the source Coverage: 3 cancer patients scored (n printed in cell J18) | Author-reported evaluation · Source checkedMethods, coverage and sourceSPOT-MAS tissue of origin, RF (validation) ctdnameth-20261009-protocol-nguyen2023-spotmas-too-validation Aggregation: Not reported Multimodal analysis of methylomics and fragmentomics in plasma cell-free DNA for multi-cancer early detection and localization; Nguyen et al. 2023, Supplementary file 1 (Tables S1-S11) · Supplementary file 1, sheet 'Table S9', K18; Validation block; row 'Lung'; column 'RF' under 'Stage II' (n in J18) |
| Configuration: SPOT-MAS tissue-of-origin Random forest (RF) | Protocol: SPOT-MAS five-class tissue of origin, independent validation cohort Dataset: SPOT-MAS validation cohort, 239 non-metastatic cancer patients (five cancer types) | 0.42 recall fraction · higher Uncertainty: Not reported by the source Coverage: 24 cancer patients scored (n printed in cell N18) | Author-reported evaluation · Source checkedMethods, coverage and sourceSPOT-MAS tissue of origin, RF (validation) ctdnameth-20261009-protocol-nguyen2023-spotmas-too-validation Aggregation: Not reported Multimodal analysis of methylomics and fragmentomics in plasma cell-free DNA for multi-cancer early detection and localization; Nguyen et al. 2023, Supplementary file 1 (Tables S1-S11) · Supplementary file 1, sheet 'Table S9', O18; Validation block; row 'Lung'; column 'RF' under 'Stage III' (n in N18) |
| Configuration: SPOT-MAS tissue-of-origin Random forest (RF) | Protocol: SPOT-MAS five-class tissue of origin, independent validation cohort Dataset: SPOT-MAS validation cohort, 239 non-metastatic cancer patients (five cancer types) | 0.5 recall fraction · higher Uncertainty: Not reported by the source Coverage: 16 cancer patients scored (n printed in cell R18) | Author-reported evaluation · Source checkedMethods, coverage and sourceSPOT-MAS tissue of origin, RF (validation) ctdnameth-20261009-protocol-nguyen2023-spotmas-too-validation Aggregation: Not reported Multimodal analysis of methylomics and fragmentomics in plasma cell-free DNA for multi-cancer early detection and localization; Nguyen et al. 2023, Supplementary file 1 (Tables S1-S11) · Supplementary file 1, sheet 'Table S9', S18; Validation block; row 'Lung'; column 'RF' under 'Non-metastasis with unknown stage' (n in R18) |
Source checking is not independent reproduction. Release 2026-10-09-ba02f2f4a36e.
ctdnameth-20261009-protocol-nguyen2023-spotmas-too-validation
Metadata review: source checked. Unreported conditions prevent automatic comparisons.
No execution recipe has been verified for this exact configuration and evaluation. A benchmark's general instructions may use different inputs, splits or model settings.
Reproducing this published result requires matching its model configuration, data, split and scorer. Source checking or a successful smoke test does not establish score reproduction.
Source checking verifies the cited claim or transcription. It does not establish independent reproduction.
Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.
One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.
36 evidence rows matching the loaded filters
| Property and statement | Original source and location | Review and provenance |
|---|---|---|
| attributes.comparison.adaptation Not reported Context-only references | Multimodal analysis of methylomics and fragmentomics in plasma cell-free DNA for multi-cancer early detection and localization Supplementary file 1 Table S9, RF columns, rows 14-19 Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: eLife 12:RP89083, version of record published 2023-10-11; PMC10567114 full-text XML | missing or unspecified No individual claim review recorded author reported Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| attributes.comparison.adaptation Not reported Context-only references | Nguyen et al. 2023, Supplementary file 1 (Tables S1-S11) Supplementary file 1 Table S9, RF columns, rows 14-19 Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: Supplementary file 1 (elife-89083-supp1.xlsx) of eLife 12:RP89083, PMC open-access copy PMC10567114.1 | missing or unspecified No individual claim review recorded author reported Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| attributes.comparison.aggregation Per cancer type and stage stratum Context-only references | Multimodal analysis of methylomics and fragmentomics in plasma cell-free DNA for multi-cancer early detection and localization Supplementary file 1 Table S9, RF columns, rows 14-19 Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: eLife 12:RP89083, version of record published 2023-10-11; PMC10567114 full-text XML | not individually reviewed No individual claim review recorded author reported Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| attributes.comparison.aggregation Per cancer type and stage stratum Context-only references | Nguyen et al. 2023, Supplementary file 1 (Tables S1-S11) Supplementary file 1 Table S9, RF columns, rows 14-19 Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: Supplementary file 1 (elife-89083-supp1.xlsx) of eLife 12:RP89083, PMC open-access copy PMC10567114.1 | not individually reviewed No individual claim review recorded author reported Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| attributes.comparison.budget Not reported Context-only references | Multimodal analysis of methylomics and fragmentomics in plasma cell-free DNA for multi-cancer early detection and localization Supplementary file 1 Table S9, RF columns, rows 14-19 Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: eLife 12:RP89083, version of record published 2023-10-11; PMC10567114 full-text XML | missing or unspecified No individual claim review recorded author reported Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| attributes.comparison.budget Not reported Context-only references | Nguyen et al. 2023, Supplementary file 1 (Tables S1-S11) Supplementary file 1 Table S9, RF columns, rows 14-19 Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: Supplementary file 1 (elife-89083-supp1.xlsx) of eLife 12:RP89083, PMC open-access copy PMC10567114.1 | missing or unspecified No individual claim review recorded author reported Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| attributes.comparison.dataset_version eLife 12:RP89083 Context-only references | Multimodal analysis of methylomics and fragmentomics in plasma cell-free DNA for multi-cancer early detection and localization Supplementary file 1 Table S9, RF columns, rows 14-19 Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: eLife 12:RP89083, version of record published 2023-10-11; PMC10567114 full-text XML | not individually reviewed No individual claim review recorded author reported Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| attributes.comparison.dataset_version eLife 12:RP89083 Context-only references | Nguyen et al. 2023, Supplementary file 1 (Tables S1-S11) Supplementary file 1 Table S9, RF columns, rows 14-19 Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: Supplementary file 1 (elife-89083-supp1.xlsx) of eLife 12:RP89083, PMC open-access copy PMC10567114.1 | not individually reviewed No individual claim review recorded author reported Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| attributes.comparison.inputs Nine concatenated SPOT-MAS cfDNA feature sets Context-only references | Multimodal analysis of methylomics and fragmentomics in plasma cell-free DNA for multi-cancer early detection and localization Supplementary file 1 Table S9, RF columns, rows 14-19 Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: eLife 12:RP89083, version of record published 2023-10-11; PMC10567114 full-text XML | not individually reviewed No individual claim review recorded author reported Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| attributes.comparison.inputs Nine concatenated SPOT-MAS cfDNA feature sets Context-only references | Nguyen et al. 2023, Supplementary file 1 (Tables S1-S11) Supplementary file 1 Table S9, RF columns, rows 14-19 Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: Supplementary file 1 (elife-89083-supp1.xlsx) of eLife 12:RP89083, PMC open-access copy PMC10567114.1 | not individually reviewed No individual claim review recorded author reported Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Release 2026-10-09-ba02f2f4a36e · Record review: source checked
Stable ID: ctdnameth-20261009-eval-nguyen2023-spotmas-too-rf-validation